The Enterprise Value as of December 2025 (TTM) for Apogee Therapeutics, Inc. (APGE) is 4.04B

According to Apogee Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.04B. This represents a change of 77.46% compared to the average of 2.28B of the last 4 quarters.

Apogee Therapeutics, Inc. (APGE) Historical Enterprise Value (quarterly & annually)

How has APGE Enterprise Value performed in the past?

The mean historical Enterprise Value of Apogee Therapeutics, Inc. over the last ten years is 1.53B. The current 4.04B Enterprise Value has changed 26.30% with respect to the historical average. Over the past ten years (40 quarters), APGE's Enterprise Value was at its highest in in the September 2024 quarter at 3.23B. The Enterprise Value was at its lowest in in the March 2022 quarter at 0.

Apogee Therapeutics, Inc. (APGE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Apogee Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Apogee Therapeutics, Inc. (APGE) Average Enterprise Value

How has APGE Enterprise Value performed in the past?

The current Enterprise Value of Apogee Therapeutics, Inc. (APGE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Apogee Therapeutics, Inc. (APGE) Enterprise Value vs. Peers

How is APGE’s Enterprise Value compared to its peers?

Apogee Therapeutics, Inc.’s Enterprise Value is less than Centessa Pharmaceuticals plc (4.05B), greater than Xenon Pharmaceuticals Inc. (3.32B), less than ASCENTAGE PHARMA GROUP INTERNATIONAL (20.23B), greater than Ultragenyx Pharmaceutical Inc. (3.33B), less than Celcuity Inc. (5.14B), greater than Zai Lab Limited (1.68B), greater than CG Oncology, Inc. Common stock (3.32B), greater than Legend Biotech Corporation (2.68B), greater than Soleno Therapeutics, Inc. (2.59B), greater than Disc Medicine, Inc. (3.43B),

Build a custom stock screener for Apogee Therapeutics, Inc. (APGE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Apogee Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Apogee Therapeutics, Inc. (APGE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Apogee Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.